The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
The multifaceted roles of chemokines in malignancy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 1×
“When analyzing the actual process of monocyte recruitment to tumors, obvious candidates responsible for high TAM presence in tumors are chemokines [12, 13, 17, 18, 40], especially CCL2 (MCP-1) and CCL5 (RANTES).”
BackgroundInvolvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,664
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
International Journal of Oncology
(2026) · International Journal of Oncology · doi:10.3892/ijo · Cited by 2,331
Bingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022
International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors
Murphy, P. M., Baggiolini, M., Charo, I. F., Hébert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., & Power, C. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01439-x · Cited by 1,817
Horder, & Harnett, W. L. (1941) · BMJ · doi:10.1136/bmj.1.4186.493 · Cited by 1,314
C hemokines in I nnate and A daptive H ost D efense : Basic Chemokinese Grammar for Immune Cells
Rot, A., & von Andrian, U. H. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104543 · Cited by 1,215
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma.
Leek, R., Lewis, C. E., Whitehouse, R. M., Greenall, M. J., Clarke, J., & Harris, A. L. (1996) · PubMed · Cited by 1,187
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.593 · Cited by 1,041
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam, C., Loda, M., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
CXC chemokines in angiogenesis
Belperio, J. A., Keane, M. P., Arenberg, D. A., Addison, C. L., Ehlert, J. E., Burdick, M. D., & Strieter, R. M. (2000) · Journal of Leukocyte Biology · doi:10.1189/jlb.68.1.1 · Cited by 804
Mig and IP-10: CXC chemokines that target lymphocytes
Farber, J. M. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.3.246 · Cited by 779
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021897 · Cited by 739
CXCR4 Regulates Growth of Both Primary and Metastatic Breast Cancer
Smith, M. C. P., Luker, K. E., Garbow, J. R., Prior, J. L., Jackson, E., Piwnica-Worms, D., & Luker, G. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1844 · Cited by 715
(2000) · PubMed · Cited by 706
The chemokine system: redundancy for robust outputs
Mantovani, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01469-3 · Cited by 704
Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A., & Strieter, R. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5269 · Cited by 575
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544 · cited 2×
“CCL20 expression was suggested to induce the accumulation of Langerhans-like DC in breast tumors [73].”
BackgroundSalcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 540
Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis
Li, Y. M., Pan, Y., Wei, Y., Cheng, X., Zhou, B. P., Tan, M., Zhou, X., Xia, W., Hortobagyi, G. N., Yu, D., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.027 · Cited by 537
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lügering, N., Domschke, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208231200 · Cited by 476
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
Scotton, C. J., Wilson, J. L., Scott, K. A., Stamp, G., Wilbanks, G. D., Fricker, S. P., Bridger, G. J., & Balkwill, F. R. (2002) · PubMed · Cited by 471
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer
Treilleux, I., Blay, J.-Y., Bendriss-Vermare, N., Ray-Coquard, I., Bachelot, T., Guastalla, J.-P., Bremond, A., Goddard, S., Pin, J.-J., Barthelemy-Dubois, C., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0684 · Cited by 460
Phillips, R. J., Burdick, M. D., Lutz, M., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200301-071oc · Cited by 455
Leek, R. D., Landers, R. J., Harris, A. L., & Lewis, C. E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690158 · Cited by 451
Bendre, M. S., Montague, D. C., Peery, T., Akel, N. S., Gaddy, D., & Suva, L. J. (2003) · Bone · doi:10.1016/s8756-3282(03)00086-3 · Cited by 428
Bachelder, R. E., Wendt, M. A., & Mercurio, A. M. (2002) · PubMed · Cited by 424
The intriguing role of polymorphonuclear neutrophils in antitumor reactions
Di Carlo, E., Forni, G., Lollini, P., Colombo, M. P., Modesti, A., & Musiani, P. (2001) · Blood · doi:10.1182/blood.v97.2.339 · Cited by 419
Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors
Crowther, M., Brown, N. J., Bishop, E. T., & Lewis, C. E. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.4.478 · Cited by 415
Critical determinants of metastasis
Fidler, I. J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0416 · Cited by 413
IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo.
Luster, A. D., & Leder, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.3.1057 · Cited by 407
Hong, K. H., Ryu, J., & Han, K. H. (2005) · Blood · doi:10.1182/blood-2004-08-3178 · Cited by 382
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 379
Azenshtein, E., Luboshits, G., Shina, S., Neumark, E., Shahbazian, D., Weil, M., Wigler, N., Keydar, I., & Ben‐Baruch, A. (2002) · PubMed · Cited by 371
Self-citationBenoy, I. H., Salgado, R., Van Dam, P., Geboers, K., Van Marck, E., Scharpé, S., Vermeulen, P. B., & Dirix, L. Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0812 · Cited by 356
Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Morris, S. B., Burdick, M. D., Glass, M. C., Taub, D. T., Iannettoni, M. D., Whyte, R. I., & Strieter, R. M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.981 · Cited by 353
Chemokine/Chemokine Receptor Nomenclature
(2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002760624305 · Cited by 353
Vicari, A. P., & Caux, C. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00033-8 · Cited by 351
Tumor-Associated Macrophages in Breast Cancer
Leek, R. D., & Harris, A. L. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1020304003704 · Cited by 351
Neville, L. F., Mathiak, G., & Bagasra, O. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00015-4 · Cited by 350
Luboshits, G., Shina, S., Kaplan, O., Engelberg, S., Nass, D., Lifshitz-Mercer, B., Chaitchik, S., Keydar, I., & Ben‐Baruch, A. (1999) · PubMed · Cited by 350
Self-citationChemokines: signal lamps for trafficking of T and B cells for development and effector function
Kim, C. H., & Broxmeyer, H. E. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.1.6 · Cited by 342
Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4
Liang, Z., Wu, T., Lou, H., Yu, X., Taichman, R. S., Lau, S. K., Nie, S., Umbreit, J., & Shim, H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3958 · Cited by 338
BENBARUCH, A. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.006 · Cited by 335
Self-citationSALCEDO, R., & OPPENHEIM, J. J. (2003) · Microcirculation · doi:10.1038/sj.mn.7800200 · Cited by 328
Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
Goede, V., Brogelli, L., Ziche, M., & Augustin, H. G. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f · Cited by 319
CCL2 (monocyte chemoattractant protein-1) and cancer
Conti, I., & Rollins, B. J. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.009 · Cited by 314
Role of CXCL1 in tumorigenesis of melanoma
Dhawan, P., & Richmond, A. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.72.1.9 · Cited by 303
Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Rossi, I., Nanni, P., De Giovanni, C., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.3.589 · Cited by 302
Ben-Baruch, A. (2002) · Breast Cancer Research · doi:10.1186/bcr554 · Cited by 300
Self-citationHall, J. M., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0438 · Cited by 293
Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., & Toi, M. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1085::aid-cncr1424>3.0.co;2-k · Cited by 288
Strieter, R. M., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., & Polverini, P. J. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1626 · Cited by 287
Tamamura, H., Hori, A., Kanzaki, N., Hiramatsu, K., Mizumoto, M., Nakashima, H., Yamamoto, N., Otaka, A., & Fujii, N. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00824-x · Cited by 285
Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · PubMed · Cited by 281
Pivotal Role of CXCR3 in Melanoma Cell Metastasis to Lymph Nodes
Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M., & Taketo, M. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1757 · Cited by 272
Kato, M., Kitayama, J., Kazama, S., & Nagawa, H. (2003) · Breast Cancer Research · doi:10.1186/bcr627 · Cited by 267
Chemokines in neoplastic progression
Zlotnik, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.004 · Cited by 266
A chemokine receptor antagonist inhibits experimental breast tumor growth.
Robinson, S. C., Scott, K. A., Wilson, J. L., Thompson, R. G., Proudfoot, A. E. I., & Balkwill, F. R. (2003) · PubMed · Cited by 259
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
Molecular Profiling of Inflammatory Breast Cancer
Bièche, I., Lerebours, F., Tozlu, S., Espie, M., Marty, M., & Lidereau, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0306 · Cited by 245
Niwa, Y., Akamatsu, H., Niwa, H., Sumi, H., Ozaki, Y., & Abe, A. (2001) · PubMed · Cited by 245
Interleukin-8/CXCL8 is a growth factor for human lung cancer cells
Zhu, Y. M., Webster, S. J., Flower, D., & Woll, P. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602227 · Cited by 241
Lee, B.-C., Lee, T.-H., Avraham, S., & Avraham, H. K. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.327.2.6 · Cited by 238
The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
Soto, H., Wang, W., Strieter, R. M., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Hedrick, J., & Zlotnik, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8205 · Cited by 236
Bendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., & Suva, L. J. (2002) · PubMed · Cited by 235
SDF-1 Activity on Microvascular Endothelial Cells
Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., Vannier, J.-P., Soria, J., Vasse, M., & Soria, C. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00292-9 · Cited by 232
Tumors and inflammatory infiltrates: Friends or foes?
Brigati, C., Noonan, D. M., Albini, A., & Benelli, R. (2002) · Clinical & Experimental Metastasis · doi:10.1023/a:1015587423262 · Cited by 230 · cited 4×
“However, under other conditions the immune cells could be suppressed or diverted into the tumor-supporting phenotype [11–14, 17–26].”
BackgroundInfluentialExpression of Functional Chemokine Receptors CXCR3 and CXCR4 on Human Melanoma Cells
Robledo, M. M., Bartolomé, R. A., Longo, N., Rodrı́guez-Frade, J. M., Mellado, M., Longo, I., van Muijen, G. N. P., Sánchez-Mateos, P., & Teixidó, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106912200 · Cited by 229
The innate immune response to tumors and its role in the induction of T‐cell immunity
Diefenbach, A., & Raulet, D. H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18802.x · Cited by 228
CXC chemokines in angiogenesis of cancer
Strieter, R. M., Belperio, J. A., Phillips, R. J., & Keane, M. P. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.006 · Cited by 218
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors
Mantovani, A., Allavena, P., Sozzani, S., Vecchi, A., Locati, M., & Sica, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.001 · Cited by 209
INTERLEUKIN-8 AS AN AUTOCRINE GROWTH FACTOR FOR HUMAN COLON CARCINOMA CELLS IN VITRO
Brew, R., Erikson, J. S., West, D. C., Kinsella, A. R., Slavin, J., & Christmas, S. E. (2000) · Cytokine · doi:10.1006/cyto.1999.0518 · Cited by 207
Lin, Y., Huang, R., Chen, L., Li, S., Shi, Q., Jordan, C., & Huang, R. (2004) · International Journal of Cancer · doi:10.1002/ijc.11724 · Cited by 205
Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-α
Robinson, S. C., Scott, K. A., & Balkwill, F. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200202)32:2<404::aid-immu404>3.0.co;2-x · Cited by 201
Chemokine receptors and melanoma metastasis
Murakami, T., Cardones, A. R., & Hwang, S. T. (2004) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2004.03.002 · Cited by 184
REGULATION OF DENDRITIC CELL RECRUITMENT BY CHEMOKINES
Caux, C., Vanbervliet, B., Massacrier, C., Aït‐Yahia, S., Vaure, C., Chemin, K., Dieu‐Nosjean, M., & Vicari, A. P. (2002) · Transplantation · doi:10.1097/00007890-200201151-00005 · Cited by 171
Malmberg, K. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0577-x · Cited by 169
CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo
Lapteva, N., Yang, A.-G., Sanders, D. E., Strube, R. W., & Chen, S.-Y. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700770 · Cited by 167
Sun, R., Gao, P. H., Chen, L., Ma, D., Wang, J., Oppenheim, J. J., & Zhang, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1163 · Cited by 163
Pantschenko, A., Pushkar, I., Anderson, K., Wang, Y., Miller, L., Kurtzman, S., Barrows, G., & Kreutzer, D. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.2.269 · Cited by 162
Porcile, C., Bajetto, A., Barbieri, F., Barbero, S., Bonavia, R., Biglieri, M., Pirani, P., Florio, T., & Schettini, G. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.04.024 · Cited by 159
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
Vicari, A. P., Aït‐Yahia, S., Chemin, K., Müeller, A., Zlotnik, A., & Caux, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1992 · Cited by 156
Ehlert, J. E., Addison, C. A., Burdick, M. D., Kunkel, S. L., & Strieter, R. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6234 · Cited by 150
Yu, J. L., & Rak, J. W. (2003) · Breast Cancer Research · doi:10.1186/bcr573 · Cited by 146 · cited 1×
“In breast carcinoma, high counts of TAM in the tumors are significantly correlated with clinical aggressiveness, high tumor grade and poor prognosis [28, 34–38].”
BackgroundExpression and growth-promoting function of the IL-8 receptor β in human melanoma cells
Norgauer, J., Metzner, B., & Schraufstätter, I. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.3.1132 · Cited by 144
MILLER, L. J., Kurtzman, S. H., Wang, Y., Anderson, K. H., Lindquist, R. R., & Kreutzer, D. L. (1998) · PubMed · Cited by 141
Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
Valković, T., Lučin, K., Krstulja, M., Dobi-Babić, R., & Jonjić, N. (1998) · Pathology - Research and Practice · doi:10.1016/s0344-0338(98)80057-5 · Cited by 137
Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer
Lebrecht, A., Grimm, C., Lantzsch, T., Ludwig, E., Hefler, L., Ulbrich, E. J., & Koelbl, H. (2004) · Tumor Biology · doi:10.1159/000077718 · Cited by 131
Immunodeficiency and cancer: prospects for correction
Hadden, J. W. (2003) · International Immunopharmacology · doi:10.1016/s1567-5769(03)00060-2 · Cited by 131
Tumor-associated macrophages: a molecular perspective
Sica, A., Saccani, A., & Mantovani, A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00064-4 · Cited by 123
Leukocyte migration: Scent of the T zone
Cyster, J. G. (2000) · Current Biology · doi:10.1016/s0960-9822(99)00253-5 · Cited by 116
Lespagnard, L., Gancberg, D., Rouas, G., Leclercq, G., Somerhausen, N. D. S.-A., Leo, A. D., Piccart, M. J., Verhest, A. P., & Larsimont, D. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3 · Cited by 113
Interleukin 8: An Autocrine Growth Factor for Human Ovarian Cancer
Xu, L., & Fidler, I. J. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747567 · Cited by 107
Yamada, M., Kim, S., Egashira, K., Takeya, M., Ikeda, T., Mimura, O., & Iwao, H. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000096208.80992.63 · Cited by 105
Soejima, K., & Rollins, B. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6576 · Cited by 101
Angiogenesis and inflammation in invasive carcinoma of the breast.
Lee, A. H., Happerfield, L. C., Bobrow, L. G., & Millis, R. R. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.8.669 · Cited by 95
Goldberg-Bittman, L., Neumark, E., Sagi‐Assif, O., et al. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.10.020 · Cited by 92
Basolo, F., Conaldi, P. G., Fiore, L., Calvo, S., & Toniolo, A. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550609 · Cited by 92
Azenshtein, E., Meshel, T., Shina, S., Barak, N., Keydar, I., & Ben‐Baruch, A. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.024 · Cited by 92
Self-citationA dual role for tumor-derived chemokine RANTES (CCL5)
Adler, E. P., Lemken, C. A., Katchen, N. S., & Kurt, R. A. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.013 · Cited by 89
Production of interleukin-6 and interleukin-8 by human mammary gland epithelial cells
Palkowetz, K. H., Royer, C. L., Garofalo, R., Rudloff, H. E., Schmalstieg, F. C., & Goldman, A. S. (1994) · Journal of Reproductive Immunology · doi:10.1016/0165-0378(93)00867-s · Cited by 88
Neuhaus, T., Stier, S., Totzke, G., Grünewald, E., Fronhoffs, S., Sachinidis, A., Vetter, H., & Ko, Y. D. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00262.x · Cited by 86
Clinical significance of CXCR3 and CXCR4 expression in primary melanoma
Longo-Imedio, M. I., Longo, N., Treviño, I., Lázaro, P., & Sánchez‐Mateos, P. (2005) · International Journal of Cancer · doi:10.1002/ijc.21269 · Cited by 84
Chemokine mediated control of dendritic cell migration and function
Gunn, M. D. (2003) · Seminars in Immunology · doi:10.1016/j.smim.2003.08.004 · Cited by 84
Suyama, T., Furuya, M., Nishiyama, M., Kasuya, Y., Kimura, S., Ichikawa, T., Ueda, T., Nikaido, T., Itô, H., & Ishikura, H. (2004) · Cancer · doi:10.1002/cncr.20747 · Cited by 80
Multiple chemotactic factors: fine control or redundancy?
Devalaraja, M. N. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01342-5 · Cited by 79
Locati, M., Otero, K., Schioppa, T., Signorelli, P., Perrier, P., Baviera, S., Sozzani, S., & Mantovani, A. (2002) · Allergy · doi:10.1034/j.1398-9995.2002.02166.x · Cited by 75
CXCR4 is Expressed in Ductal Carcinoma in situ of the Breast and in Atypical Ductal Hyperplasia
Schmid, B. C., Rudas, M., Rezniczek, G. A., Leodolter, S., & Zeillinger, R. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000019962.18922.87 · Cited by 73
Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity
Palmer, K., Hitt, M., Emtage, P. C. R., Gyorffy, S., & Gauldie, J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301386 · Cited by 71
Kanda, S., Mochizuki, Y., & Kanetake, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204771200 · Cited by 64
Neumark, E., Sagi‐Assif, O., Shalmon, B., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11337 · Cited by 61
Thomachot, M. C., Bendriss‐Vermare, N., Massacrier, C., Biota, C., Treilleux, I., Goddard‐Léon, S., Caux, C., Bachelot, T., Blay, J., & Ménétrier‐Caux, C. (2004) · International Journal of Cancer · doi:10.1002/ijc.20146 · Cited by 58
Inhibition of metastasis by inhibition of tumor-derived CCL5
Stormes, K. A., Lemken, C. A., Lepre, J. V., Marinucci, M., & Kurt, R. A. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-5328-3 · Cited by 55
Chemokine Receptor Desensitization in Tumor-Bearing Mice
Kurt, R. A., Baher, A., Wisner, K. P., Tackitt, S., & Urba, W. J. (2001) · Cellular Immunology · doi:10.1006/cimm.2000.1754 · Cited by 55
Tumour-associated macrophages in breast cancer and their prognostic correlations
Volodko, N., Reiner, A., Rudas, M., & Jakesz, R. (1998) · The Breast · doi:10.1016/s0960-9776(98)90065-0 · Cited by 53
Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines
Vicari, A. P., Treilleux, I., & Lebecque, S. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.002 · Cited by 51
Changes of cytokines and thyroid function in patients with recurrent breast cancer.
Yokoe, T., Iino, Y., Takei, H., Horiguchi, J., Koibuchi, Y., Maemura, M., Ohwada, S., & Morishita, Y. (1997) · PubMed · Cited by 50
Impact of tumor-derived CCL2 on T cell effector function
Vitiello, P. F., Shainheit, M. G., Allison, E. M., Adler, E. P., & Kurt, R. A. (2004) · Immunology Letters · doi:10.1016/j.imlet.2003.12.009 · Cited by 46
Prest, S. J., Rees, R. C., Murdoch, C., et al. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1006657109866 · Cited by 42
Neumark, E., Anavi, R., Witz, I. P., & Ben‐Baruch, A. (1999) · Immunology Letters · doi:10.1016/s0165-2478(99)00043-7 · Cited by 39
Self-citationGoldberg-Bittman, L., Sagi‐Assif, O., Meshel, T., Nevo, I., Levy‐Nissenbaum, O., Yron, I., Witz, I. P., & Ben‐Baruch, A. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.003 · Cited by 37
Self-citationMetzner, B. M., Hofmann, C., Heinemann, C., Zimpfer, U., Schraufstätter, I. U., Schöpf, E., & Norgauer, J. (1999) · Oncology Reports · doi:10.3892/or.6.6.1405 · Cited by 33
Valković, T., Čupić, D. F., Štifter, S., Matušan‐Ilijaš, K., Hasan, M., Dobrila, F., & Jonjić, N. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0667-3 · Cited by 29
Expression of the Chemokines IP-10 and Mig in IL-10 Transduced Tumors
Sun, H., Kundu, N., Dorsey, R. M., Jackson, M. J., & Fulton, A. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200103000-00008 · Cited by 25
Possible co-regulation of genes associated with enhanced progression of mammary adenocarcinomas
Neumark, E., Cohn, M. A., Lukanidin, E. M., Witz, I. P., & Ben‐Baruch, A. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00026-3 · Cited by 20
Self-citationToulza, F., Eliaou, J., & Pinet, V. (2005) · International Journal of Cancer · doi:10.1002/ijc.20705 · Cited by 17
Ben‐Baruch, A. (2005) · Springer eBooks · doi:10.1007/1-4020-3414-8_11 · Cited by 9
Self-citationMoog-Lutz (1997) · Pure Amsterdam UMC · doi:10.1002/(sici)1097-0215(19970410)71:2
Cited by
Cox, T. R., & Erler, J. T. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.004077 · Cited by 1,569
The inflammatory chemokines CCL2 and CCL5 in breast cancer
Soria, G., & Ben-Baruch, A. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.018 · Cited by 593
Self-citationRole of chemokines in tumor growth
Raman, D., Baugher, P. J., Thu, Y. M., & Richmond, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.05.013 · Cited by 578
Induction of Lymphoidlike Stroma and Immune Escape by Tumors That Express the Chemokine CCL21
Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M., & Swartz, M. A. (2010) · Science · doi:10.1126/science.1185837 · Cited by 506
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Xu, M., Wang, Y., Xia, R., Wei, Y., & Wei, X. (2021) · Cell Proliferation · doi:10.1111/cpr.13115 · Cited by 382
Metadata
- Authors
- Ben-Baruch, A.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2006-10-03
- Volume
- 25
- Issue
- 3
- Pages
- 357-371
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2069207808
- Cited by
- 259
- References
- 141
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.